Equity Vaccines To Launch Malaria Vaccine Trials In Nigeria

Equity Vaccines To Launch Malaria Vaccine Trials In Nigeria

Equity Vaccines To Launch Malaria Vaccine Trials In Nigeria …C0NTINUE READING HERE >>>

Equity Vaccines Ltd., a pioneering subsidiary of the Equity Health Group, has set to begin clinical trials for its innovative malaria vaccine in Nigeria, marking a critical milestone in the battle against one of Africa’s most pressing public health challenges.

The company, which has been collaborating with a reputable Nigerian university, was nearing the completion of the pre-clinical stage of the vaccine’s development.

This ambitious project is part of Equity Vaccines’ plan to…

>

Be the first to comment

Leave a Reply

Your email address will not be published.


*